Gachon University Gil Hospital Mobile

Schedule / Obstetrics & Gynecology

Schedule / VIP Health Promotion Center

Schedule / 부인종양센터

※ The schedule can be changed without notice.
CALL (1577-2299)

---

Education

1998	Seoul National University College of Medicine, M.D.
2007	Seoul National University College of Medicine, M.S.
2015	Seoul National University College of Medicine, Ph.D.

Career

1998	Seoul National University Hospital, Intern
1999	Medical Officer
2002	Department of Obstetrics and Gynecology, Seoul National University Hospital, Resident
2006	Department of Obstetrics and Gynecology, Seoul National University Hospital, Fellow
2007	Department of Obstetrics and Gynecology, Gachon University Gil Medical Center, Fellow
2008	Department of Obstetrics and Gynecology, Gachon University Gil Medical Center, Assistant Professor
2012	Department of Obstetrics and Gynecology, Gachon University Gil Medical Center, Associate Professor
2018~	Department of Obstetrics and Gynecology, Gachon University Gil Medical Center, Professor
2019~	Director of Crisis Intervention Center for Women and Children, Incheon
2019~	Deputy director of Referral Center, Gachon University Gil Medical Center

Community

Training

2015	City of Hope Medical Center (Gynecologic Oncology), USA

License

1998	Medical License
2006	Obstetrics and Gynecology Specialist
2015	Gynecological Oncologist

Paper

2019	Lee NH, Park SR, Lee JW, Lim S, Lee SH, Nam S, et al. SERPINB2 Is a Novel Indicator of Cancer Stem Cell Tumorigenicity in Multiple Cancer Types. Cancers 2019;11
2018	Seo ES, Lee SH, Chon SJ, Jung SY, Cho YJ, Lim S. Influence of previous abdominal surgery on clinical outcomes of patients undergoing total laparoscopic hysterectomy. Obstet Gynecol Sci 2018;61:379-85.
2018	Lee SH, Cho YJ, Cho KJ, Ko MH, Jung SY, Chon SJ, et al. Effect of tibolone on the survival of early stage cervical adenocarcinoma patients. Obstet Gynecol Sci 2018;61:584-9.
2018	Lee SH, Cho KJ, Ko MH, Cho HY, Lee KB, Lim S. Factors associated with parametrial involvement in patients with stage IB1 cervical cancer: Who is suitable for less radical surgery? Obstet Gynecol Sci 2018;61:88-94.
2017	Lim S, Lee S, Choi J, Chon S, Lee K, Shin J. Safety of total laparoscopic hysterectomy in patients with prior cesarean section. J Obstet Gynaecol Res 2017;43:196-201.
2017	Lim S, Cho K, Lee S, Lee K, Shin J, Chung D, et al. Effect of number of retrieved lymph nodes on prognosis in FIGO stage IB-IIA cervical cancer patients treated with primary radical surgery. J Obstet Gynaecol Res 2017;43:211-9.
2017	Lee S, Choi S, Lee Y, Chung D, Hong S, Park N. Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer. J Obstet Gynaecol Res 2017;43:220-7.
2014	Yang SH, Kong SK, Lee SH, Lim SY, Park CY. Human papillomavirus 18 as a poor prognostic factor in stage I-IIA cervical cancer following primary surgical treatment. Obstet Gynecol Sci 2014;57:492-500.
2014	Ku CH, Lee SH, Lee SP. Effect of human papillomavirus genotype on severity and prognosis of cervical intraepithelial neoplasia. Obstet Gynecol Sci 2014;57:37-43.
2014	Chung DH, Lee SH, Lee KB. A case of ovarian steroid cell tumor, not otherwise specified, treated with surgery and gonadotropin releasing hormone agonist. J Menopausal Med 2014;20:39-42.
2010	Lee SH, Lee KB, Shin JW, Chung DH, Park CY. Ovarian malignant melanoma without evidence of teratoma. J Obstet Gynaecol Res 2010;36:898-901.
2009	Lee SH, Ku CH, Lee KB, Shin JW, Park CY. Decreased bone mineral density of femur in patients with cervical cancer. J Obstet Gynaecol Res 2009;35:335-8.